Your browser doesn't support javascript.
loading
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Zaloum, Safiya A; Wood, Callum H; Tank, Pooja; Upcott, Matthew; Vickaryous, Nicola; Anderson, Valerie; Baker, David; Chance, Randy; Evangelou, Nikos; George, Katila; Giovannoni, Gavin; Harding, Katharine E; Hibbert, Aimee; Ingram, Gillian; Jolles, Stephen; Kang, Angray S; Loveless, Samantha; Moat, Stuart J; Richards, Aidan; Robertson, Neil P; Rios, Francesca; Schmierer, Klaus; Willis, Mark; Dobson, Ruth; Tallantyre, Emma C.
Afiliación
  • Zaloum SA; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Wood CH; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Tank P; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Upcott M; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Vickaryous N; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Anderson V; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Baker D; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Chance R; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK/Centre for Oral Immunobiology and Regenerative Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Evangelou N; Clinical Neurology, Academic Unit of Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK.
  • George K; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Giovannoni G; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK/Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK/Department of Neurology, Barts Health NHS Trust, London, UK.
  • Harding KE; Department of Neurology, Royal Gwent Hospital, Newport, UK.
  • Hibbert A; Clinical Neurology, Academic Unit of Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, UK.
  • Ingram G; Department of Neurology, Morriston Hospital, Swansea, UK.
  • Jolles S; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK/School of Medicine, Cardiff University, Cardiff, UK.
  • Kang AS; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK/Centre for Oral Immunobiology and Regenerative Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Loveless S; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Moat SJ; Wales Newborn Screening Laboratory, Department of Medical Biochemistry, Immunology and Toxicology, University Hospital of Wales, Cardiff, UK/School of Medicine, Cardiff University, Cardiff, UK.
  • Richards A; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Robertson NP; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK/Department of Neurology, University Hospital of Wales, Cardiff, UK.
  • Rios F; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Schmierer K; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK/Department of Neurology, Barts Health NHS Trust, London, UK.
  • Willis M; Department of Neurology, University Hospital of Wales, Cardiff, UK.
  • Dobson R; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK/Department of Neurology, Barts Health NHS Trust, London, UK.
  • Tallantyre EC; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK/Department of Neurology, University Hospital of Wales, Cardiff, UK.
Mult Scler ; 29(8): 979-989, 2023 07.
Article en En | MEDLINE | ID: mdl-37431627
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido